BioCryst Pharmaceuticals Inc
XBER:BO1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BioCryst Pharmaceuticals Inc
XBER:BO1
|
US |
|
H
|
Huaneng Power International Inc
XMUN:HUP1
|
CN |
|
A
|
Australian Mines Ltd
F:MJH
|
AU |
|
Public Power Corporation SA
OTC:PUPOF
|
GR |
|
Pfizer Ltd
BSE:500680
|
IN |
Shareholder Yield
Current shareholder yield for 
BO1 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
BO1 Price
BioCryst Pharmaceuticals Inc
| Average Annual Return | -10.2% |
| Standard Deviation of Annual Returns | 33.02% |
| Max Drawdown | -78% |
| Market Capitalization | 2.1B EUR |
| Shares Outstanding | 206 380 000 |
| Percentage of Shares Shorted |
N/A
|
